Management expects net sales to be in the range of $342 to $348 million, gross margin to be approximately 52.5% to 54.5% and adjusted earnings per share in the range of $0.01 to $0.06 as it continues to invest in new product launches to drive future growth.
Related Posts
Ping Identity Holding Q2 EPS $(0.34) Down From $0.11 YoY, Sales $72.00M Miss $73.19M Estimate
Ping Identity Holding (NYSE:PING) reported quarterly losses of $(0.34) per share. This is a 409.09 percent decrease over earnings of $0.11 per share from the same period last year. The company reported quarterly sales
Humanigen Has Received A Notice Of Allowance For Its U.S. Patent Application 16/652,977 Titled “Methods Of Treating Immunotherapy-Related Toxicity Using A GM-CSF Antagonist”.
https://patentcenter.uspto.gov/#!/applications/16652977/ifw/docs
